OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules
Ilaria Galgani, Eveline M. Bunge, Lisa Hendriks, et al.
Expert Review of Vaccines (2017) Vol. 16, Iss. 9, pp. 919-932
Open Access | Times Cited: 16
Ilaria Galgani, Eveline M. Bunge, Lisa Hendriks, et al.
Expert Review of Vaccines (2017) Vol. 16, Iss. 9, pp. 919-932
Open Access | Times Cited: 16
Showing 16 citing articles:
Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines
Daniel Růžek, Tatjana Avšič‐Županc, J Borde, et al.
Antiviral Research (2019) Vol. 164, pp. 23-51
Closed Access | Times Cited: 339
Daniel Růžek, Tatjana Avšič‐Županc, J Borde, et al.
Antiviral Research (2019) Vol. 164, pp. 23-51
Closed Access | Times Cited: 339
Tick-borne encephalitis (TBE) in children in Europe: Epidemiology, clinical outcome and comparison of vaccination recommendations
Robert Steffen
Ticks and Tick-borne Diseases (2018) Vol. 10, Iss. 1, pp. 100-110
Open Access | Times Cited: 61
Robert Steffen
Ticks and Tick-borne Diseases (2018) Vol. 10, Iss. 1, pp. 100-110
Open Access | Times Cited: 61
Vector Specificity of Arbovirus Transmission
Marine Viglietta, Rachel Bellone, Adrien Blisnick, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 41
Marine Viglietta, Rachel Bellone, Adrien Blisnick, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 41
Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence
Jiřı́ Beran, Maria Lattanzi, Fang Xie, et al.
Vaccine (2018) Vol. 37, Iss. 32, pp. 4623-4629
Open Access | Times Cited: 33
Jiřı́ Beran, Maria Lattanzi, Fang Xie, et al.
Vaccine (2018) Vol. 37, Iss. 32, pp. 4623-4629
Open Access | Times Cited: 33
Tick-borne encephalitis virus seroprevalence and infection incidence in Switzerland, 2020–2021
Arthur Brêchet, Philipp Köhler, Tamara Dörr, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Arthur Brêchet, Philipp Köhler, Tamara Dörr, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Can the booster interval for the tick-borne encephalitis (TBE) vaccine ‘FSME-IMMUN’ be prolonged? — A systematic review
Robert Steffen, Wendy N. Erber, Schmitt Hj
Ticks and Tick-borne Diseases (2021) Vol. 12, Iss. 5, pp. 101779-101779
Open Access | Times Cited: 23
Robert Steffen, Wendy N. Erber, Schmitt Hj
Ticks and Tick-borne Diseases (2021) Vol. 12, Iss. 5, pp. 101779-101779
Open Access | Times Cited: 23
Retrospective, matched case–control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006–2020
Kyra D. Zens, Sarah R. Haile, Axel J. Schmidt, et al.
BMJ Open (2022) Vol. 12, Iss. 4, pp. e061228-e061228
Open Access | Times Cited: 16
Kyra D. Zens, Sarah R. Haile, Axel J. Schmidt, et al.
BMJ Open (2022) Vol. 12, Iss. 4, pp. e061228-e061228
Open Access | Times Cited: 16
Immunogenicity and safety of the tick-borne encephalitis vaccination (2009–2019): A systematic review
John Ethan Rampa, Helena Hervius Askling, Phung Lang, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101876-101876
Open Access | Times Cited: 23
John Ethan Rampa, Helena Hervius Askling, Phung Lang, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101876-101876
Open Access | Times Cited: 23
Host immunogenetics in tick-borne encephalitis virus infection—The CCR5 crossroad
Joel Henrique Ellwanger, José Artur Bogo Chies
Ticks and Tick-borne Diseases (2019) Vol. 10, Iss. 4, pp. 729-741
Closed Access | Times Cited: 18
Joel Henrique Ellwanger, José Artur Bogo Chies
Ticks and Tick-borne Diseases (2019) Vol. 10, Iss. 4, pp. 729-741
Closed Access | Times Cited: 18
Defining the “Correlate(s) of Protection” to tick-borne encephalitis vaccination and infection – key points and outstanding questions
Rahel Ackermann‐Gäumann, Phung Lang, Kyra D. Zens
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Rahel Ackermann‐Gäumann, Phung Lang, Kyra D. Zens
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules
Marco Costantini, Andrea Callegaro, Jiřı́ Beran, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 9, pp. 2274-2279
Open Access | Times Cited: 7
Marco Costantini, Andrea Callegaro, Jiřı́ Beran, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 9, pp. 2274-2279
Open Access | Times Cited: 7
Clinical course and neurological sequels after tick-borne encephalitis in children – case report
Ilona Pałyga-Bysiecka, Beata Kręcisz, Barbara Szczepańska
Annals of Agricultural and Environmental Medicine (2021) Vol. 29, Iss. 1, pp. 162-167
Open Access | Times Cited: 5
Ilona Pałyga-Bysiecka, Beata Kręcisz, Barbara Szczepańska
Annals of Agricultural and Environmental Medicine (2021) Vol. 29, Iss. 1, pp. 162-167
Open Access | Times Cited: 5
Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
Marco Costantini, Andrea Callegaro, Jiřı́ Beran, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 9, pp. 2282-2284
Open Access | Times Cited: 3
Marco Costantini, Andrea Callegaro, Jiřı́ Beran, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 9, pp. 2282-2284
Open Access | Times Cited: 3
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up
Jiřı́ Beran, Maria Lattanzi, Marco Costantini, et al.
Vaccine (2023) Vol. 41, Iss. 23, pp. 3518-3524
Open Access | Times Cited: 1
Jiřı́ Beran, Maria Lattanzi, Marco Costantini, et al.
Vaccine (2023) Vol. 41, Iss. 23, pp. 3518-3524
Open Access | Times Cited: 1
Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons
David Jilich, Marek Malý, Pavel Kosina, et al.
Epidemiology and Infection (2021) Vol. 149
Open Access | Times Cited: 2
David Jilich, Marek Malý, Pavel Kosina, et al.
Epidemiology and Infection (2021) Vol. 149
Open Access | Times Cited: 2
Tickborne Encephalitis Vaccines
Joachim Hombach, Alan D.T. Barrett, Malin Trabold, et al.
Elsevier eBooks (2023), pp. 1142-1157.e6
Closed Access
Joachim Hombach, Alan D.T. Barrett, Malin Trabold, et al.
Elsevier eBooks (2023), pp. 1142-1157.e6
Closed Access
